Menkes disease

Zeynep Tümer; Lisbeth B Møller

doi:10.1038/ejhg.2009.187

Menkes disease

Zeynep Tümer, Lisbeth B Møller

Medical Genetics Program

180 Citations (Scopus)

Abstract

Menkes disease (MD) is a lethal multisystemic disorder of copper metabolism. Progressive neurodegeneration and connective tissue disturbances, together with the peculiar kinky hair are the main manifestations. MD is inherited as an X-linked recessive trait, and as expected the vast majority of patients are males. MD occurs due to mutations in the ATP7A gene and the vast majority of ATP7A mutations are intragenic mutations or partial gene deletions. ATP7A is an energy dependent transmembrane protein, which is involved in the delivery of copper to the secreted copper enzymes and in the export of surplus copper from cells. Severely affected MD patients die usually before the third year of life. A cure for the disease does not exist, but very early copper-histidine treatment may correct some of the neurological symptoms.

Original language	English
Journal	European Journal of Human Genetics
Volume	18
Issue number	5
Pages (from-to)	511-8
Number of pages	7
ISSN	1018-4813
DOIs	https://doi.org/10.1038/ejhg.2009.187
Publication status	Published - May 2010

Access to Document

10.1038/ejhg.2009.187

Cite this

@article{26e258e0963711df928f000ea68e967b,

title = "Menkes disease",

abstract = "Menkes disease (MD) is a lethal multisystemic disorder of copper metabolism. Progressive neurodegeneration and connective tissue disturbances, together with the peculiar kinky hair are the main manifestations. MD is inherited as an X-linked recessive trait, and as expected the vast majority of patients are males. MD occurs due to mutations in the ATP7A gene and the vast majority of ATP7A mutations are intragenic mutations or partial gene deletions. ATP7A is an energy dependent transmembrane protein, which is involved in the delivery of copper to the secreted copper enzymes and in the export of surplus copper from cells. Severely affected MD patients die usually before the third year of life. A cure for the disease does not exist, but very early copper-histidine treatment may correct some of the neurological symptoms.",

author = "Zeynep T{\"u}mer and M{\o}ller, {Lisbeth B}",

note = "Keywords: Adenosine Triphosphatases; Animals; Cation Transport Proteins; Copper; Disease Models, Animal; Humans; Menkes Kinky Hair Syndrome; Mutation; Phenotype",

year = "2010",

month = may,

doi = "10.1038/ejhg.2009.187",

language = "English",

volume = "18",

pages = "511--8",

journal = "European Journal of Human Genetics",

issn = "1018-4813",

publisher = "nature publishing group",

number = "5",

}

TY - JOUR

T1 - Menkes disease

AU - Tümer, Zeynep

AU - Møller, Lisbeth B

N1 - Keywords: Adenosine Triphosphatases; Animals; Cation Transport Proteins; Copper; Disease Models, Animal; Humans; Menkes Kinky Hair Syndrome; Mutation; Phenotype

PY - 2010/5

Y1 - 2010/5

N2 - Menkes disease (MD) is a lethal multisystemic disorder of copper metabolism. Progressive neurodegeneration and connective tissue disturbances, together with the peculiar kinky hair are the main manifestations. MD is inherited as an X-linked recessive trait, and as expected the vast majority of patients are males. MD occurs due to mutations in the ATP7A gene and the vast majority of ATP7A mutations are intragenic mutations or partial gene deletions. ATP7A is an energy dependent transmembrane protein, which is involved in the delivery of copper to the secreted copper enzymes and in the export of surplus copper from cells. Severely affected MD patients die usually before the third year of life. A cure for the disease does not exist, but very early copper-histidine treatment may correct some of the neurological symptoms.

AB - Menkes disease (MD) is a lethal multisystemic disorder of copper metabolism. Progressive neurodegeneration and connective tissue disturbances, together with the peculiar kinky hair are the main manifestations. MD is inherited as an X-linked recessive trait, and as expected the vast majority of patients are males. MD occurs due to mutations in the ATP7A gene and the vast majority of ATP7A mutations are intragenic mutations or partial gene deletions. ATP7A is an energy dependent transmembrane protein, which is involved in the delivery of copper to the secreted copper enzymes and in the export of surplus copper from cells. Severely affected MD patients die usually before the third year of life. A cure for the disease does not exist, but very early copper-histidine treatment may correct some of the neurological symptoms.

U2 - 10.1038/ejhg.2009.187

DO - 10.1038/ejhg.2009.187

M3 - Review

C2 - 19888294

SN - 1018-4813

VL - 18

SP - 511

EP - 518

JO - European Journal of Human Genetics

JF - European Journal of Human Genetics

IS - 5

ER -

Menkes disease

Abstract

Access to Document

Fingerprint

Cite this